SS Innovations International, Inc. (NASDAQ: SSII) has announced its participation in two upcoming investor conferences. Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer, and Dr. Vishwa Srivastava, Chief Executive Officer – Asia Pacific, will be representing the company.
At the UBS Global Healthcare Conference in Palm Beach Gardens, FL on Tuesday, November 11, 2025, the management will be available for one-on-one and small group meetings throughout the day.
Following this, at the Stifel 2025 Healthcare Conference in New York, NY on Wednesday, November 12, 2025, a group presentation is scheduled for 4:40 p.m. Eastern Time. Similar to the previous conference, the management will also be available for one-on-one and small group meetings throughout the day.
A live webcast and replay of the Stifel group presentation will be accessible on the company’s website at https://ssinnovations.com/investor-overview/.
SS Innovations International, Inc. is known for developing innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible to a larger segment of the global population. The company’s product range includes its proprietary "SSI Mantra" surgical robotic system and its comprehensive suite of "SSI Mudra" surgical instruments, which support a variety of surgical procedures, including robotic cardiac surgery. The company, headquartered in India, plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. As a result of these announcements, the company's shares have moved 2.46% on the market, and are now trading at a price of $9.98. If you want to know more, read the company's complete 8-K report here.
